Related references
Note: Only part of the references are listed.Effect of IL-12B, IL-2, TGF-β1, and IL-4 Polymorphism and Expression on Hepatitis B Progression
Roli Saxena et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2014)
Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development
Lingmin Hu et al.
HEPATOLOGY (2012)
Relationships between tumour necrosis factor-a, interleukin-12B and interleukin-10 gene polymorphisms and hepatitis B in Chinese Han haemodialysis patients
Cuiyu Wang et al.
NEPHROLOGY (2012)
IL12 polymorphisms, HBV infection and risk of hepatocellular carcinoma in a high-risk Chinese population
Li Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Low serum osteocalcin level is a potential marker for metabolic syndrome: results from a Chinese male population survey
Aihua Tan et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Genetic polymorphisms in the cytokine genes and risk of hepatocellular carcinoma in low-risk non-Asians of USA
Simona Ognjanovic et al.
CARCINOGENESIS (2009)
Interactions of IL-12A and IL-12B Polymorphisms on the Risk of Cervical Cancer in Chinese Women
Xiaojun Chen et al.
CLINICAL CANCER RESEARCH (2009)
Contribution of IL-12R mediated feedback loop to Th1 cell differentiation
Attila Becskei et al.
FEBS LETTERS (2007)
Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China
Kyoung-Mu Lee et al.
CARCINOGENESIS (2007)
SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci
YY Shi et al.
CELL RESEARCH (2005)
NF-κB functions as a tumour promoter in inflammation-associated cancer
E Pikarsky et al.
NATURE (2004)
Interleukin-12 and the regulation of innate resistance and adaptive immunity
G Trinchieri
NATURE REVIEWS IMMUNOLOGY (2003)
Hepatitis B e antigen and the risk of hepatocellular carcinoma
HI Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice
P Nanni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Share Paper
